COVID-19 risk score as a public health tool to guide targeted testing: A demonstration study in Qatar
View ORCID ProfileLaith J. Abu-Raddad, View ORCID ProfileSoha Dargham, View ORCID ProfileHiam Chemaitelly, View ORCID ProfilePeter Coyle, View ORCID ProfileZaina Al Kanaani, View ORCID ProfileEinas Al Kuwari, View ORCID ProfileAdeel A. Butt, View ORCID ProfileAndrew Jeremijenko, View ORCID ProfileAnvar Hassan Kaleeckal, Ali Nizar Latif, Riyazuddin Mohammad Shaik, View ORCID ProfileHanan F. Abdul Rahim, View ORCID ProfileGheyath K. Nasrallah, View ORCID ProfileHadi M. Yassine, Mohamed G. Al Kuwari, Hamad Eid Al Romaihi, Mohamed H. Al-Thani, Abdullatif Al Khal, View ORCID ProfileRoberto Bertollini
doi: https://doi.org/10.1101/2021.03.06.21252601
Laith J. Abu-Raddad
1Infectious Disease Epidemiology Group, Weill Cornell Medicine-Qatar, Cornell University, Doha, Qatar
2World Health Organization Collaborating Centre for Disease Epidemiology Analytics on HIV/AIDS, Sexually Transmitted Infections, and Viral Hepatitis, Weill Cornell Medicine–Qatar, Cornell University, Qatar Foundation – Education City, Doha, Qatar
3Department of Population Health Sciences, Weill Cornell Medicine, Cornell University, New York, New York, USA
Soha Dargham
1Infectious Disease Epidemiology Group, Weill Cornell Medicine-Qatar, Cornell University, Doha, Qatar
2World Health Organization Collaborating Centre for Disease Epidemiology Analytics on HIV/AIDS, Sexually Transmitted Infections, and Viral Hepatitis, Weill Cornell Medicine–Qatar, Cornell University, Qatar Foundation – Education City, Doha, Qatar
Hiam Chemaitelly
1Infectious Disease Epidemiology Group, Weill Cornell Medicine-Qatar, Cornell University, Doha, Qatar
2World Health Organization Collaborating Centre for Disease Epidemiology Analytics on HIV/AIDS, Sexually Transmitted Infections, and Viral Hepatitis, Weill Cornell Medicine–Qatar, Cornell University, Qatar Foundation – Education City, Doha, Qatar
Peter Coyle
4Hamad Medical Corporation, Doha, Qatar
Zaina Al Kanaani
4Hamad Medical Corporation, Doha, Qatar
Einas Al Kuwari
4Hamad Medical Corporation, Doha, Qatar
Adeel A. Butt
3Department of Population Health Sciences, Weill Cornell Medicine, Cornell University, New York, New York, USA
4Hamad Medical Corporation, Doha, Qatar
Andrew Jeremijenko
4Hamad Medical Corporation, Doha, Qatar
Anvar Hassan Kaleeckal
4Hamad Medical Corporation, Doha, Qatar
Ali Nizar Latif
4Hamad Medical Corporation, Doha, Qatar
Riyazuddin Mohammad Shaik
4Hamad Medical Corporation, Doha, Qatar
Hanan F. Abdul Rahim
5College of Health Sciences, QU Health, Qatar University, Doha, Qatar
Gheyath K. Nasrallah
6Biomedical Research Center, Member of QU Health, Qatar University, Doha, Qatar
7Department of Biomedical Science, College of Health Sciences, Member of QU Health, Qatar University, Doha, Qatar
Hadi M. Yassine
6Biomedical Research Center, Member of QU Health, Qatar University, Doha, Qatar
7Department of Biomedical Science, College of Health Sciences, Member of QU Health, Qatar University, Doha, Qatar
Mohamed G. Al Kuwari
8Primary Health Care Corporation, Doha, Qatar
Hamad Eid Al Romaihi
9Ministry of Public Health, Doha, Qatar
Mohamed H. Al-Thani
9Ministry of Public Health, Doha, Qatar
Abdullatif Al Khal
4Hamad Medical Corporation, Doha, Qatar
Roberto Bertollini
9Ministry of Public Health, Doha, Qatar
Data Availability
All relevant data are available within the manuscript.
Posted March 09, 2021.
COVID-19 risk score as a public health tool to guide targeted testing: A demonstration study in Qatar
Laith J. Abu-Raddad, Soha Dargham, Hiam Chemaitelly, Peter Coyle, Zaina Al Kanaani, Einas Al Kuwari, Adeel A. Butt, Andrew Jeremijenko, Anvar Hassan Kaleeckal, Ali Nizar Latif, Riyazuddin Mohammad Shaik, Hanan F. Abdul Rahim, Gheyath K. Nasrallah, Hadi M. Yassine, Mohamed G. Al Kuwari, Hamad Eid Al Romaihi, Mohamed H. Al-Thani, Abdullatif Al Khal, Roberto Bertollini
medRxiv 2021.03.06.21252601; doi: https://doi.org/10.1101/2021.03.06.21252601
COVID-19 risk score as a public health tool to guide targeted testing: A demonstration study in Qatar
Laith J. Abu-Raddad, Soha Dargham, Hiam Chemaitelly, Peter Coyle, Zaina Al Kanaani, Einas Al Kuwari, Adeel A. Butt, Andrew Jeremijenko, Anvar Hassan Kaleeckal, Ali Nizar Latif, Riyazuddin Mohammad Shaik, Hanan F. Abdul Rahim, Gheyath K. Nasrallah, Hadi M. Yassine, Mohamed G. Al Kuwari, Hamad Eid Al Romaihi, Mohamed H. Al-Thani, Abdullatif Al Khal, Roberto Bertollini
medRxiv 2021.03.06.21252601; doi: https://doi.org/10.1101/2021.03.06.21252601
Subject Area
Subject Areas
- Addiction Medicine (383)
- Allergy and Immunology (699)
- Anesthesia (192)
- Cardiovascular Medicine (2853)
- Dermatology (244)
- Emergency Medicine (430)
- Epidemiology (12561)
- Forensic Medicine (10)
- Gastroenterology (806)
- Genetic and Genomic Medicine (4434)
- Geriatric Medicine (402)
- Health Economics (716)
- Health Informatics (2850)
- Health Policy (1049)
- Hematology (375)
- HIV/AIDS (893)
- Medical Education (413)
- Medical Ethics (114)
- Nephrology (462)
- Neurology (4194)
- Nursing (222)
- Nutrition (617)
- Oncology (2204)
- Ophthalmology (624)
- Orthopedics (254)
- Otolaryngology (318)
- Pain Medicine (268)
- Palliative Medicine (82)
- Pathology (486)
- Pediatrics (1172)
- Primary Care Research (483)
- Public and Global Health (6783)
- Radiology and Imaging (1490)
- Respiratory Medicine (900)
- Rheumatology (430)
- Sports Medicine (369)
- Surgery (473)
- Toxicology (57)
- Transplantation (202)
- Urology (174)